⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Study To Assess Long Term Safety Of Pazopanib

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Study To Assess Long Term Safety Of Pazopanib

Official Title: An Open-Label, Phase Ib Study to Assess the Long Term Safety Profile of Pazopanib in Cancer Patients

Study ID: NCT00387205

Conditions

Carcinoma, Renal Cell

Interventions

Pazopanib

Study Description

Brief Summary: This study was a rollover study to evaluate the long term safety of pazopanib and to continue to provide pazopanib to patients who participated in a GSK sponsored pazopanib study until pazopanib is available commercially.

Detailed Description:

Keywords

chronic administration

monotherapy and combination therapies

solid

lapatinib (TYKERB, TYVERB)

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Novartis Investigative Site, Duarte, California, United States

Novartis Investigative Site, Santa Monica, California, United States

Novartis Investigative Site, Aurora, Colorado, United States

Novartis Investigative Site, Indianapolis, Indiana, United States

Novartis Investigative Site, Detroit, Michigan, United States

Novartis Investigative Site, Minneapolis, Minnesota, United States

Novartis Investigative Site, Lebanon, New Hampshire, United States

Novartis Investigative Site, New Brunswick, New Jersey, United States

Novartis Investigative Site, Buffalo, New York, United States

Novartis Investigative Site, Durham, North Carolina, United States

Novartis Investigative Site, Cleveland, Ohio, United States

Novartis Investigative Site, Greenville, South Carolina, United States

Novartis Investigative Site, Nashville, Tennessee, United States

Novartis Investigative Site, Houston, Texas, United States

Novartis Investigative Site, Tacoma, Washington, United States

Novartis Investigative Site, Lyon Cedex 08, , France

Novartis Investigative Site, Singapore, , Singapore

Novartis Investigative Site, Sutton, Surrey, United Kingdom

Novartis Investigative Site, Newcastle Upon Tyne, , United Kingdom

Contact Details

Name: Novartis Pharmaceuticals

Affiliation: Novartis Pharmaceuticals

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: